SureTrader Nadex Advertisement
Home > Boards > Stock Clubs > Technical Analysis >

TRADING SA, MNKD,VRX,SRPT

RSS Feed
      Hide Sticky   Hide Intro
Moderator: TREND1 Assistants:
Search This Board: 
Last Post: 2/19/2017 12:45:43 PM - Followers: 1 - Board type: Premium - Posts Today: 0

TRADING SA
PostSubject
#67   https://en.wikipedia.org/wiki/Artificial_pancreas TREND1 02/19/17 12:45:43 PM
#66   MannKind - Afrezza Sales Slip As New Sales TREND1 02/17/17 04:02:13 PM
#65   MannKind, Afrezza Sales, And 'Free Beer Tomorrow' TREND1 02/10/17 06:30:03 PM
#63   MannKind - Afrezza Sales Improve Slightly, But Not TREND1 02/03/17 07:40:01 PM
#62   MannKind: The Saga Of Smoking Guns TREND1 02/03/17 01:04:43 PM
#61   MannKind Announces Plans For Reverse Split TREND1 02/02/17 11:14:27 AM
#60   Afrezza Sales Still Low As MannKind Prepares For TREND1 01/27/17 07:22:37 PM
#59   MannKind: Afrezza Sales Start Off 2017 Modestly. Will TREND1 01/18/17 10:57:51 AM
#58   MannKind Sells Building, Extends Cash Runway: The Good TREND1 01/12/17 08:30:19 PM
#57   MannKind's (MNKD) CEO Matt Pfeffer Presents at JPMorgan TREND1 01/12/17 05:08:17 PM
#56   MannKind Afrezza Sales - Closing Out The Year TREND1 01/09/17 10:04:29 AM
#55   1/3 MannKind's $1M Milestone: Good News, But Barely TREND1 01/03/17 04:34:37 PM
#54   1/3 Does A Possible Label Change On Afrezza TREND1 01/03/17 01:32:31 PM
#53   No Sizzle To The Afrezza Fizzle TREND1 12/30/16 05:45:25 PM
#52   MannKind: Will Afrezza's Holiday Lull Transform Into A TREND1 12/27/16 02:27:22 PM
#51   MannKind: Afrezza Sales Still Having Trouble With Traction TREND1 12/18/16 08:33:35 PM
#50   MannKind: Thanksgiving Week Takes Toll On Afrezza Scripts TREND1 12/02/16 12:58:16 PM
#49   2 Key Reasons MannKind Needs To Remain On Nasdaq TREND1 11/29/16 05:23:03 PM
#48   MannKind Finally Comes Clean And Faces Reality TREND1 11/29/16 01:00:00 PM
#47   MannKind - Afrezza Scripts Still Low As Year-End TREND1 11/28/16 05:23:23 PM
#46   MannKind's Earnings Beat Doesn't Change Much TREND1 11/23/16 09:58:45 AM
#45   MannKind's Afrezza Sales Remain Below 300 Scripts - TREND1 11/21/16 12:57:09 PM
#44   MannKind - Afrezza Scripts Increase, Runway Extended, But TREND1 11/14/16 11:38:07 AM
#43   MannKind Announces Q3 Profit, Extends Financial Runway, But TREND1 11/11/16 03:43:39 PM
#42   MannKind's (MNKD) CEO Matthew Pfeffer on Q3 2016 TREND1 11/10/16 01:33:00 PM
#41   MannKind: Afrezza Sales Fizzle Going Into Quarterly Call TREND1 11/04/16 03:47:18 PM
#40   MannKind's Q3 Conference Call - What Investors Should TREND1 11/01/16 01:55:50 PM
#39   MannKind Stock Price Slides As Afrezza Sales Lose Traction TREND1 10/28/16 03:52:06 PM
#38   *****MannKind - Afrezza Scripts Dip Again - About TREND1 10/21/16 06:01:17 PM
#37   ******MannKind - Afrezza Scripts Finally Pass 300 - TREND1 10/14/16 04:31:40 PM
#36   *** ** MannKind Finishes Q3 With Weak Afrezza Sales TREND1 10/07/16 01:46:08 PM
#35   ***** MannKind-Afrezza Scripts Slide: What To Focus On TREND1 09/30/16 03:00:29 PM
#34   User-Defined Scans: Results TREND1 09/29/16 11:12:08 AM
#33   ***** Mannkind: New Prescription Sales Create Double Digit Gains TREND1 09/27/16 11:25:17 AM
#32   ***** MannKind: Afrezza Scripts Approach 300; Trajectory Is TREND1 09/26/16 11:15:09 AM
#31   ***** MannKind Receives De-Listing Notice From NASDAQ - TREND1 09/23/16 11:15:05 AM
#30   ***** MannKind - Take A Deep Breath, Afrezza TREND1 09/21/16 11:20:44 AM
#29   *****MannKind: My Public Response To MannKind's Chief Commercial Officer TREND1 09/20/16 11:35:05 AM
#28   MNKD TREND1 09/14/16 06:52:30 PM
#27   AG MNKD VRX SRPT DAILY TREND1 09/12/16 01:30:31 PM
#26   *****MannKind: Investors Need To Be Realistic TREND1 09/09/16 03:10:41 PM
#25   AG MNKD VRX SRPT DAILY TREND1 09/07/16 01:05:51 PM
#24   ***** MannKind - 2 Months Into Relaunch Of TREND1 09/02/16 02:45:31 PM
#22   MNKD H D W MONTHLY TREND1 09/02/16 02:07:20 PM
#21   for 8/25/16 265/8000 3.3 % of SCRIPTS needed TREND1 09/02/16 12:59:04 PM
#20   *****Don't Buy The MannKind EpiPen Hype TREND1 09/01/16 11:28:53 AM
#19   *****MannKind: EpiPen Breathes New Life Into The Stock TREND1 09/01/16 11:24:14 AM
#18   IND Investigational new drug Therapeutics A status assigned TREND1 08/31/16 12:16:58 PM
#17   Micro cap MannKind (MNKD +13.4%) tries to regain TREND1 08/31/16 12:11:06 PM
#16   *****MannKind - Afrezza Scripts, Class Actions Suits, Nasdaq TREND1 08/30/16 11:30:45 AM
PostSubject